Search Results
Search results for "plant based protein 2025"
-
Plant Veda Receives License from CFIA to Produce Branded Products at New Facility
VANCOUVER, British Columbia--(BUSINESS WIRE)--Plant Veda Foods Ltd. (CSE:MILK) (the “Company” or “Plant Veda”), an award-winni…https://www.biomb.ca/news/business-wire/articles/749/bw-24b0f94f620bafad47547e935ef288bf -
Heritage Cannabis Enters Exclusive Partnership to Commercialize Avicanna’s Evidence-Based Topical Products through Heritage’s Medical Opticann Brands
Exclusive licensing of certain of Avicanna’s advanced and evidence-based CBD topical products including its deep tissue and skin care formulations. Heritage …https://www.biomb.ca/news/business-wire/articles/919/bw-d05109fe1943186ccb1bf5a1f4b32be1 -
Plant Forward
…oronto, ON Join the leaders of the next generation of food to connect, collaborate and innovate at Plant Forward. CONNECT with international experts and share your perspective. COLLABORATE t…https://www.biomb.ca/events/event/1636 -
Global Protein Labeling Market Report to 2028 - Featuring Thermo Fisher Scientific, Merck and PerkinElmer Among Others - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Global Protein Labeling Market Size, Share & Industry Trends Analysis Report By Method, By Produ…https://www.biomb.ca/news/business-wire/articles/2404/bw-15867ad23431784295ca9e113c3c2c9c -
Organic Garage’s Future of Cheese Engages US-Based Sales & Marketing Firm Oxford Hill Partners to Support North American Growth Strategy
… 9CW1 | OTCQX: OGGFF), one of Canada’s leading independent grocers, is pleased to announce that its plant-based food company, Future of Cheese Inc. (“Future of Chee TORONTO--(BUSIN…https://www.biomb.ca/news/business-wire/articles/1302/bw-40353f90b357964aa58bec8d1fb9eb81 -
Valence Discovery Announces $8.5 Million in Seed Funding to Scale AI-Based Generative Chemistry Engine and Collaborations with Leading Discovery Organizations
Valence’s AI-based generative chemistry engine designs novel chemical matter optimized for complex propert…https://www.biomb.ca/news/business-wire/articles/1481/bw-fc71fbaab70ef5a6a476cbfca5172b08 -
Avilar Therapeutics to Present In Vivo Non-Human Primate Data on ASGPR-Targeting Chimeras (ATACs) at the Keystone Symposium on Targeted Protein Degradation
…, Mass.--(BUSINESS WIRE)--Avilar Therapeutics, a biopharmaceutical company focused on extracellular protein degradation, today announced it will present preclinical data demonstrating the degra…https://www.biomb.ca/news/business-wire/articles/2639/bw-fd3442e6a94ef6bf849c2244860965c9 -
Fluence Announces Strawberry Research Results, Revealing Higher Yields and Better Plant Quality Under Broad-Spectrum Lighting Strategies
…As with all crops and individual cultivars, there is no ubiquitous lighting strategy for optimizing plant yield and quality. However, our global research endeavors continue to showcase the powe…https://www.biomb.ca/news/business-wire/articles/1618/bw-fe3aee210a438e710fa76ef68f82d1da -
Flora Growth CEO to Deliver Keynote Address at Plant Medicine Week Conference in Malta
…nds, announced today that the Company’s Chairman and CEO Luis Merchan is the keynote speaker at the Plant Medicine Week conference held at the Mediterranean Conference Centre in Valletta, Malta…https://www.biomb.ca/news/business-wire/articles/1869/bw-db1454b6e089387f67d4434e7805cf25 -
Vaxess Announces Production of The First GMP Batch of MIMIX™ Technology Vaccine Patches for an Upcoming Phase 1 Seasonal Influenza Clinical Trial; Clinical Entry Expected This Summer Based on a Successful February Pre-CTA Meeting With Health Canada.
…a, combines GC’s commercial seasonal influenza vaccine antigen with Vaxess’s innovative MIMIX patch-based intradermal controlled release delivery system. MIMIX-Flu offers ease of topical applic…https://www.biomb.ca/news/business-wire/articles/1889/bw-1e73a0efc7ac9e06151ca6bf890ba9b2